Vascular smooth muscle relaxation by α-adrenoceptor blocking action of dobutamine in isolated rabbit aorta

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 1, 1996, Pages 33-36

  Aikawa, Jo ^a   Fukazawa, Masayuki ^a   Ishikawa, Michiro ^a   Moroi, Masao ^a   Namiki, Atsushi ^a   Yamaguchi, Tetsu ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenoceptor blocking action; Cyclic AMP; Dobutamine; Isolated rabbit thoracic aorta; Vascular smooth muscle relaxation

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE; PHENYLEPHRINE; PROPRANOLOL; PROSTAGLANDIN F2; RECEPTOR SUBTYPE;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ANIMAL TISSUE; AORTA; ARTICLE; DRUG MECHANISM; HEART VENTRICLE FUNCTION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR BINDING; SMOOTH MUSCLE RELAXATION; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

ABORTIFACIENT AGENTS; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; ANIMALS; AORTA, THORACIC; DINOPROST; DOBUTAMINE; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; PHENYLEPHRINE; PROPRANOLOL; RABBITS; VASODILATION;

EID: 0030061334     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199601000-00006     Document Type: Article

References (13)

1. Akhtar N, Mikulic E, Cohn JN, Chaudhry MH. Hemodynamic effect of dobutamine in patients with severe heart failure. Am J Cardiol 1975;36:202-5.
2. Leier CV, Webel J, Bush CA. The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure. Circulation 1977;56:468-72.
3. Robie NW, Nutter DO, Moody C, McNay JL. In vivo analysis of adrenergic receptor activity of dobutamine. Circ Res 1974;34:663-71.
4. Tuttle RR, Mills J. Development of a new catecholamine to selectivity increase cardiac contractility. Circ Res 1975;36: 185-96.
5. Ozaki N, Kawakita S, Toda N. Effects of dobutamine on isolated canine cerebral, coronary, mesenteric, and renal arteries. J Cardiovasc Pharmacol 1982;4:456-61.
6. Morishita H, Furukawa T. Possible modes of action of dobutamine in dog femoral and pulmonary arteries. Cardiovasc Res 1980;14:103-7.
7. Williams RS, Bishop T. Selectivity of dobutamine for adrenergic receptor subtypes, in vitro analysis by radioligand binding. J Clin Invest 1981;67:1703-11.
8. Arunlakshana G, Schild HO. Some quantitative uses of drug antagonists. Br J Pharmacol 1959;14:48-58.
9. Aikawa J, Moroi M, Namiki A, et al. A difference in vascular smooth muscle relaxation of denopamine and isoproterenol. J Jpn Coll Angiol 1990;30:1137-42.
10. Kanmura Y, Yoshimura N. Effect of dopamine and dobutamine on vascular smooth muscles. Jpn J Anesthesiol 1995; 44:2-9.
11. Ariens EJ. Steric structure and activity of catecholamines on α- and β-receptors. Proceedings of the First International Pharmacological Meeting. New York: Pergamon Press, 1963;7:247-64.
12. 1adrenoceptor blocking action of denopamine in isolated rabbit aorta. J Cardiovasc Pharmacol 1991; 17:440-4.
13. Leier CV, Unverferth DV, Kates RE. The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failure. Am J Med 1979;66:238-42.